Improve the outcomes for patients with neuroblastoma

The SIOPEN Association brings together clinicians from across Europe and beyond to improve the outcomes for patients with neuroblastoma.

International collaboration is vital because neuroblastoma is uncommon. Collaboration ensures there are enough patients to do clinical studies.

This allows us to learn more about the condition and improve treatments. SIOPEN runs a number of large clinical trials examining how best to treat neuroblastoma. In addition, it leads research into the biology of neuroblastoma to provide a better understanding of how the disease develops and how these different types respond to treatment.

There are Speciality Committees which focus on specific areas such as biology, pathology, imaging techniques, molecular monitoring of response and surgery.

Latest News

News
Arceci Innovation award
Arceci Innovation award

The Arceci Innovation award is back this year and ready for nominations.

The Fight Kids Cancer and St Baldrick's foundation sponsors it. This is a “genius” award of €250,000 a year for 4 years (€1 million in total) to support innovative childhood cancer research, targeted to investigators in their first 10 years of academic appointment at a European institution. 

SIOPEN AGM 2024 - Feedback survey
SIOPEN AGM 2024 - Feedback survey
In memory of Tom Monclair
In memory of Tom Monclair

In memory of Tom Monclair, who was a dedicated pediatric surgeon, a pilar for SIOPEN over so many years, and very appreciated by his colleagues who valued very much his clinical experience and opinion. SIOPEN was honored and blessed to have known Tom, our sincerest condolences to his loved ones.

New website page: Statements
New website page: Statements

New website page including the SIOPEN position statement on the use of DFMO

SIOPEN Grant Call 2024 - Winners
SIOPEN Grant Call 2024 - Winners

Among several proposals evaluated, SIOPEN is delighted to announce that 2 were selected as the winners for the Grant Call 2024 and to be funded by SIOPEN with a total of 200.000€ each. Congratulations to Dr Rosswog and Dr Taschner-Mandl!!

SIOPEN - Having access to the same treatment across Europe.

Membership of SIOPEN is open to physicians, scientists and other healthcare professionals actively involved in the care of patients with, or research into, neuroblastoma.

SIOPEN Events

Featured
ITCC Annual Meeting Paris 2024
Nov 28
ITCC Annual Meeting Paris 2024

Registration is open until full capacity or until November 10th, whichever occurs first.

SIOPEN Translational Research meeting 2025
Jan 29
SIOPEN Translational Research meeting 2025

See more

Solving Kids’ Cancer UK Parents Conference
Mar 8
Solving Kids’ Cancer UK Parents Conference

The SKC conferences are free to attend, bringing families together with the research and healthcare communities to learn about the latest in neuroblastoma research, and to share their experiences. Through insightful talks and discussions, as well as the opportunity to put questions to the experts, the conferences aim to inform families and empower their discussion making.